NOVONIX Statistics
Total Valuation
NOVONIX has a market cap or net worth of 245.33 million. The enterprise value is 268.25 million.
| Market Cap | 245.33M |
| Enterprise Value | 268.25M |
Important Dates
The next estimated earnings date is Wednesday, February 26, 2025.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.37% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 453.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 1.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.72 |
| EV / Sales | 41.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.09 |
Financial Position
The company has a current ratio of 6.15, with a Debt / Equity ratio of 0.45.
| Current Ratio | 6.15 |
| Quick Ratio | 5.28 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.36 |
| Interest Coverage | -13.60 |
Financial Efficiency
Return on equity (ROE) is -26.03% and return on invested capital (ROIC) is -12.73%.
| Return on Equity (ROE) | -26.03% |
| Return on Assets (ROA) | -12.22% |
| Return on Capital (ROIC) | -12.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.94% in the last 52 weeks. The beta is 1.59, so NOVONIX's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | -6.94% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 44.67 |
| Average Volume (20 Days) | 203,645 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NOVONIX had revenue of 6.88 million and -46.86 million in losses. Loss per share was -0.10.
| Revenue | 6.88M |
| Gross Profit | 5.82M |
| Operating Income | -51.01M |
| Pretax Income | -47.06M |
| Net Income | -46.86M |
| EBITDA | -46.76M |
| EBIT | -51.01M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 47.13 million in cash and 71.73 million in debt, giving a net cash position of -24.60 million.
| Cash & Cash Equivalents | 47.13M |
| Total Debt | 71.73M |
| Net Cash | -24.60M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 158.07M |
| Book Value Per Share | 0.32 |
| Working Capital | 48.48M |
Cash Flow
In the last 12 months, operating cash flow was -37.25 million and capital expenditures -15.49 million, giving a free cash flow of -52.74 million.
| Operating Cash Flow | -37.25M |
| Capital Expenditures | -15.49M |
| Free Cash Flow | -52.74M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 84.63% |
| Operating Margin | -741.99% |
| Pretax Margin | -684.50% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NOVONIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.37% |
| Shareholder Yield | -0.37% |
| Earnings Yield | -21.39% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NOVONIX has an Altman Z-Score of 0.2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.2 |
| Piotroski F-Score | n/a |